V
Victor L. Yu
Researcher at Veterans Health Administration
Publications - 33
Citations - 3992
Victor L. Yu is an academic researcher from Veterans Health Administration. The author has contributed to research in topics: Legionella & Community-acquired pneumonia. The author has an hindex of 16, co-authored 33 publications receiving 3771 citations. Previous affiliations of Victor L. Yu include Wake Forest University.
Papers
More filters
Journal ArticleDOI
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
M. Hong Nguyen,James E. Peacock,Arthur J. Morris,David C. Tanner,Minh Ly Nguyen,David R. Snydman,Marilyn M. Wagener,Michael G. Rinaldi,Victor L. Yu +8 more
TL;DR: In this large scale study, the non-C.
Journal ArticleDOI
Distribution of Legionella Species and Serogroups Isolated by Culture in Patients with Sporadic Community-Acquired Legionellosis: An International Collaborative Survey
Victor L. Yu,Joseph F. Plouffe,Maddalena Castellani Pastoris,Janet E. Stout,M. I. Schousboe,Andreas F. Widmer,James T. Summersgill,Thomas M. File,Christopher M. Heath,David L. Paterson,David L. Paterson,Annette Chereshsky +11 more
TL;DR: This international collaborative survey identified culture-confirmed Legionellosis in 508 patients with sporadic community-acquired legionellosis and identified the Legionella species most commonly isolated in Australia and New Zealand.
Journal ArticleDOI
International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial Infections
David L. Paterson,Wen Chien Ko,Anne von Gottberg,Sunlta Mohapatra,Jose Maria Casellas,Herman Goossens,Lutfiye Mulazimoglu,Gordon M. Trenholme,Kelth P. Klugman,Robert A. Bonomo,Louis B. Rice,Marilyn M. Wagener,Joseph G. McCormack,Victor L. Yu +13 more
TL;DR: ESBL-producing gram-negative bacilli were found to truly be multiresistant pathogens and were resistant to all -lactam antibiotics, most aminoglycosides, trimethoprimsulfamethoxazole, and sometimes the fluoroquinolones.
Journal ArticleDOI
Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum β-Lactamases
David L. Paterson,David L. Paterson,Wen Chien Ko,Anne von Gottberg,Sunita Mohapatra,Jose Maria Casellas,Herman Goossens,Lutfiye Mulazimoglu,Gordon M. Trenholme,Keith P. Klugman,Robert A. Bonomo,Louis B. Rice,Marilyn M. Wagener,Joseph G. McCormack,Victor L. Yu +14 more
TL;DR: Multivariate analysis including other predictors of mortality showed that use of a carbapenem during the 5-day period after onset of bacteremia due to an ESBL-producing organism was independently associated with lower mortality.
Journal ArticleDOI
Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary.
Joseph W. Chow,Victor L. Yu +1 more
TL;DR: A review of selected clinical studies suggests that combination therapy is associated with improved outcome typically only in severely ill patients and its efficacy may be further limited to those with Pseudomonas aeruginosa, Klebsiella spp, or Enterobacter spp.